New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Fractyl Health, Inc. (GUTS) vs Quantum Biopharma Ltd. (QNTM)
- Fractyl Health, Inc. GUTS 0.82 −14.58%
- Quantum Biopharma Ltd. QNTM 1.29 −9.15%
Fractyl Health, Inc. and Quantum Biopharma Ltd. are both Biotechnology companies. Fractyl Health, Inc. and Quantum Biopharma Ltd. are of similar size ($12.7M and $12.6M). Quantum Biopharma Ltd. has the higher net margin (−16,880.7% vs −75,732.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Quantum Biopharma Ltd. leads on 9 and Fractyl Health, Inc. on 5.
Valuation
Profitability
| Metric | GUTS | QNTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 46.24% | (1,068.29%) | 70.18% |
| Operating margin | (100,570.97%) | (9,699.83%) | 0.00% |
| Net margin | (75,732.26%) | (16,880.72%) | 0.00% |
| Free cash flow margin | (72,350.54%) | (6,089.39%) | 0.00% |
| Return on equity | 905.17% | (233.09%) | (51.58%) |
| Return on assets | (82.35%) | (127.92%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack